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Abstract The present study was designed to investigate
the role of pre- and postnatal manganese (Mn) exposure on
hydroxyl radical (HO•) formation in the brains of dopamine (DA) partially denervated rats (Parkinsonian rats).
Wistar rats were given tap water containing 10,000 ppm
manganese chloride during the duration of pregnancy and
until the time of weaning. Control rat dams consumed tap
water without added Mn. Three days after birth, rats of
both groups were treated with 6-hydroxydopamine at one
of three doses (15, 30, or 67 lg, intraventricular on each
side), or saline vehicle. We found that Mn content in the
brain, kidney, liver, and bone was significantly elevated in
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dams exposed to Mn during pregnancy. In neonates, the
major organs that accumulated Mn were the femoral bone
and liver. However, Mn was not elevated in tissues in
adulthood. To determine the possible effect on generation
of the reactive species, HO• in Mn-induced neurotoxicity,
we analyzed the contents of 2.3- and 2.5-dihydroxybenzoic
acid (spin trap products of salicylate; HO• being an index
of in vivo HO• generation), as well as antioxidant enzyme
activities of superoxide dismutase (SOD) isoenzymes and
glutathione S-transferase (GST). 6-OHDA-depletion of DA
produced enhanced HO• formation in the brain tissue of
newborn and adulthood rats that had been exposed to Mn,
and the latter effect did not depend on the extent of DA
denervation. Additionally, the extraneuronal, microdialysate, content of HO• in neostriatum was likewise elevated
in 6-OHDA-lesioned rats. Interestingly, there was no difference in extraneuronal HO• formation in the neostriatum
of Mn-exposed versus control rats. In summary, findings in
this study indicate that Mn crosses the placenta but in
contrast to other heavy metals, Mn is not deposited long
term in tissues. Also, damage to the dopaminergic system
acts as a ‘‘trigger mechanism,’’ initiating a cascade of
adverse events leading to a protracted increase in HO•
generation, and the effects of Mn and 6-OHDA are compounded. Moreover, HO• generation parallels the suppression of SOD isoenzymes and GST in the brains of rats
lesioned with 6-OHDA and/or intoxicated with Mn—the
most prominent impairments being in frontal cortex, striatum, and brain stem. In conclusion, ontogenetic Mn
exposure, resulting in reactive oxygen species, HO• formation, represents a risk factor for dopaminergic neurotoxicity and development of neurodegenerative disorders.
Keywords Manganese  Ontogenetic  6hydroxydopamine  Brain  Hydroxyl radicals  Rats
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Introduction
Manganese (Mn) is an enzymatic cofactor that plays an
important role in a number of physiologic processes.
However, when present at high tissue concentration, Mn
produces cellular toxicity, including neurotoxicity in brain.
Although the mechanisms by which Mn induces neuronal
damage are not well defined, Mn neurotoxicity appears to
be regulated by a number of factors, including oxidative
injury, mitochondrial dysfunction, and neuroinflammation
(Milatovic et al. 2007, 2009; Zhang et al. 2013). Occupational Mn exposure results in an imbalance between
dopamine (DA) and c-aminobutyric acid (GABA) in the
basal ganglia, eliciting the syndrome called manganism,
which shares multiple features with Parkinson’s disease
(Huang 2007). The strongest correlation between any type
of environmental exposure and increased susceptibility to
Parkinsonism is observed in the Mn-exposed population
(Gorell et al. 1999; Racette et al. 2001).
Occupational exposure (miners, smelters, welders, and
workers in dry-cell battery factories; also inhalation of Mn
in aerosols/dusts) accounts for the major source of Mn
intoxication in humans. An important but non-occupational
source of Mn is methylcyclopentadienyl manganese tricarbonyl (MMT), the antiknock agent in gasoline. Another
source is potassium permanganate, a powerful oxidizing
agent for purifying drinking water, treating waste water,
and as an agricultural fungicidal and bactericidal agent
(Huang 2007). Manganism has been observed recently in
intravenous methcathinone abusers because this substance
is illicitly produced by a potassium permanganate oxidation process (Stepens et al. 2008). Additionally, Mn is a
natural component of many foods, particularly of nuts,
grains, and tea, and is an essential trace element used by
humans in enzymatic processes. There are numerous
reports of Mn intoxication related to long-term total parenteral nutrition (Reynolds et al. 1994; Reimund et al.
2000).
The effects of Mn on the adult mammalian brain have
been studied for decades in connection with manganism.
However, the risk of Mn-induced neurotoxicity during
brain development, both pre- and postnatally, has received
little attention. Several studies report the aftereffects (e.g.,
reduced intellectual function) of Mn exposure on children
at various developmental stages (Woolf et al. 2002;
Wasserman et al. 2006). Mn crosses the placenta to impair
embryonic development (Spencer 1999) and produce
behavioral abnormalities through childhood and into
adulthood (Kwieciński and Nowak 2009; Nowak et al.
2010, 2011; Brus et al. 2012; Szkilnik et al. 2014). It is
evident that Mn in excess is toxic to human embryos and
fetuses (Colomina et al. 1996). The progressive and latent
nature of some neurodegenerative disorders (e.g.,
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Parkinson’s disease) suggest that the triggering event for
these disorders occurs much sooner than the appearance of
visible symptoms. In humans, only after the loss of about
80 % of pars compacta substantia nigra DA neurons do
symptoms (e.g., Parkinsonian tremor) arise. Therefore, it is
important to identify possible environmental trigger(s), to
pinpoint the period during which such factors pose the
greatest risk, and to determine the mechanism(s) involved.
The current study was conducted in order to assess the
effects of paired gestational Mn exposure with overt
dopaminergic neurotoxicity (i.e., 6-hydroxydopamine,
6-OHDA) on hydroxyl radical (HO•) production in rat
brain. A better understanding of the causes of HO• production in brain and the effects of on neurodegenerative
processes are especially important because the brain is at
high risk for oxidative injury because of (1) high levels of
oxygen consumption combined with (2) low catalase,
superoxide dismutase, and glutathione peroxidase activity,
(3) high iron concentration, and (4) elevated polysaturated
fatty acid content of neuronal membranes (Halliwell 2006).

Materials and Methods
Animals and Treatment
Pregnant Wistar rats, 220–250 g, were used in this study.
All rats were housed in a well-ventilated room at
22 ± 2 C with a 12 h light/dark cycle. From the first day
of pregnancy (as determined by the presence of vaginal
plugs), rats were singly housed with free access to pelleted
food (Altromin-1324, Lage, Germany) and tap water containing 10,000 ppm manganese chloride (MnCl24H2O;
POCh Ltd., Gliwice, Poland). Control rats received water
without Mn. Fluid consumption by each dam was monitored daily. Three days after birth, rats from both groups
(control and Mn-exposed) were pretreated with desipramine hydrochloride (20 mg/kg, i.p., base; 1 h; Sigma – a
norepinephrine transport inhibitor) and pargyline hydrochloride (50 mg/kg, i.p., salt form; 0.5 h; Sigma) to protect
noradrenergic neurons. Rats were then given bilateral
intracerebroventricular (i.c.v.) injections with 6-OHDA
hydrobromide at one of three doses (15, 30, or 67 lg, salt
form, on each side). Control animals received injections of
vehicle, consisting of 0.85 % saline and 0.1 % ascorbic
acid. This procedure has been described in detail elsewhere
(Gong et al. 1993). Rats were weaned on postnatal day 21
(P21), at which time Mn was discontinued, and male offspring was group housed until experimentation. This
experiment was approved by the local Bioethical Committee for Animals, Medical University of Silesia (permission no 19/06 issued on 01.03.2006). All procedures,
reviewed and approved by the Institutional Animal Care
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Committee, are in accordance with the principles and
guidelines described in the NIH booklet Care and Use of
Laboratory Animals.
Manganese Assay
Mn was assayed in control and Mn-exposed dams immediately following parturition. Rats were sacrificed; and the
frontal cortex, neostriatum, and hippocampus were dissected. The kidney, liver, femoral bone, femoral muscle,
and heart muscle also were taken as samples. Mn levels
were estimated in both control and Mn-exposed rats at P14
and P56. Approximately, 100 mg of each tissue was dissolved in 1.0 ml of ultra-pure nitric acid (Merck). Next,
Mn2? content was assayed using SP-2900 Pye Unicam AA
(Cambridge, UK) atomic absorption spectrometer and
handled according to the Company’s brochure (Whiteside
1976). Results were presented in lg/g wet tissue.
Assessment of 2.3- and 2.5-dihydroxybenzoic Acid
and Salicylic Acid in Dissected Tissue
The indirect method of Giovanni et al. (1995) was applied
for assessment of HO• generation. This method is based on
quantitative, chromatographic measurement of 2.3-dihydroxybenzoic acid (2.3-DHBA), 2.5-dihydroxybenzoic
acid (2.5-DHBA), and salicylic acid in the examined part
of the brain. Control and Mn-intoxicated rats were injected
with salicylic acid (100 mg/kg, i.p.), 30 min before
decapitation. In 14-day-old offspring, the right hemisphere
was taken for analysis; in 8-week-old rats, the frontal
cortex, hippocampus, neostriatum, thalamus, cerebellum,
and pons were dissected and frozen on dry ice and stored at
-80 C until analysis. Tissue samples were homogenized
for 15–20 s. in ice-cold trichloracetic acid (0.1 M) with
0.05 mM ascorbic acid. After centrifugation (5,0009g for
10 min), the supernatants were filtered through 0.2 lm
cellulose membranes (Titan MSF Microspin Filters, Scientific Resources Inc., Eatontown, GB) and supernatants
were injected onto a DHBA-250, 250 9 4 mm, 5 lm
column (ESA, USA). Mobile phase consisted of 50 mM
sodium acetate (Merck), 50 mM citric acid (Merck), 25 %
methanol (J.T. Backer), and 5 % isopropanol (Merck)
adjusted to pH 2.5 with phosphoric acid (Fluka). Flow rate
was set at 0.5 ml/min. A guard cell at a potential of
?775 mV, an E1 electrode at ?250 mV and 50 nA/V
sensitivity, and an E2 electrode at ?750 mV and 10 lA/V
sensitivity were used for 2.3- and 2.5-DHBA and salicylic
acid analysis. A Coulochem data analysis system was used
to integrate peak areas. Results obtained from 2.3- and 2.5DHBA assays are presented in units of nanogram per gram
of wet tissue (ng/g), and results from salicylic acid assays
are given in lg/g.
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Assessment of 2.3- and 2.5-dihydroxybenzoic Acid Via
In Vivo Microdialysis
Cannula implantation for in vivo microdialysis was performed in urethane-anesthetized rats. Rats were first placed
in a stereotaxic frame. Diazepam (Polfa; 10 mg/kg, i.p.) and
ketamine (Parke-Davis; 80 mg/kg, i.p.) were used to provide
anesthesia, while the skin and tissue were retracted to expose
the skull overlying the neostriatum. A small hole was drilled
to allow implantation of the dialysis probe, with 4 mm
active membrane delivered (ID 75 lm, OD 150 lm,
Polymicron Technologies, USA) into the right neostriatum
(A ?0.7, L ?3.0, V –7.0), coordinates by Paxinos and
Watson (1986). Two stainless steel screws were mounted to
the cranium near the probe, and this assembly was fixed in
place with dental cement (Duracryl Plus, Spofa, Praha). On
the following day, rats were injected with urethane (1.5 g/
kg, i.p.), and the free ends of the probe were connected with
Teflon tubes and continuously perfused at a flow rate of
2.0 ll/min (Microdialysis pump, Harvard Apparatus Model
22, GB) with artificial cerebrospinal fluid (aCSF), consisting
of 145 mM NaCl (Merck), 2.7 mM KCl (Fisher), 1.0 mM
MgCl26H2O (Aldrich), 1.2 mM CaCl22H2O (Aldrich), and
2.0 mM Na2HPO4 (Fluka), adjusted to pH 7.4 with phosphoric acid (Fluka). Samples were collected every 22 min
and injected directly onto a DHBA-250, 250 9 4 mm, 5 lm
column (ESA, USA) with the mobile phase contents the
same as for DHBA tissue analysis. After 3 periods of sampling, aCSF was replaced with aCSF containing 5 mM salicylic acid. A guard cell at a potential of ?775 mV, an E1
electrode at ?250 mV with 50 nA/V sensitivity, and an E2
electrode at ?750 mV with 10 lA/V sensitivity were used
for 2.3- and 2.5-DHBA analysis. The study was continued
until 220 min. Final results of the 2.3- and 2.5-DHBA were
expressed in picograms (pg) in 20 ll capacity of loop
samples (Takeda et al. 1990; Nowak et al. 2008, 2010).
Determination of Superoxide Dismutase (SOD)
Activity
The method of Oyanagui (1984) was used to measure the
activity of SOD. In this method, xanthine oxidase produces
superoxide anions which react with hydroxylamine, forming nitric ions. These ions react with naphthalene diamine
and sulfanilic acid, generating a colored product. The
concentration of this product is proportional to the amount
of generated superoxide anions and negatively proportional
to the activity of SOD. Absorbance was measured using an
automated Perkin Elmer analyzer at wavelength of 550 nm.
The enzymatic activity of SOD was expressed in nitric
units. The isoenzymes of SOD, such as Mn-SOD and
CuZn-SOD, were also assessed, using KCN as the inhibitor
of the CuZn-SOD activity. The activity of SOD is equal to
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1 nitric unit (NU) when it inhibits nitric ion production by
50 %. Activities of SOD were expressed in NU/mg protein.
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Results
Manganese Assay

Determination of Glutathione Reductase (GR) Activity
The activity of GR was measured according to Richterich
(1971) using an automated Perkin Elmer analyzer. The
activity was expressed as lmoles of NADPH utilized per
minute per g (U/g protein).
Determination of Glutathione S-transferase (GST)
Activity
The activity of GST was measured according to the kinetic
method of Habig and Jakoby (1981) using an automated
Perkin Elmer analyzer. The activity of GST was expressed
as lmoles of thioether produced per minute per g protein
(U/g protein).
Determination of Glutathione Peroxidase (GPx)
Activity

Mn content in the frontal cortex, hippocampus, and neostriatum was significantly elevated in dams exposed to
this metal during pregnancy and until weaning of pups, as
compared to control rats [Fig. 1]. Additionally, significant
elevations in Mn concentration were observed in the
kidney, liver, and bone. Conversely, the Mn content in the
femoral muscle and heart muscle was in the range of the
respective control values [Fig. 2]. The primary organs
showing accumulation of Mn in P14 pups from Mnexposed mothers were the femoral bones and liver.
Interestingly, there were no significant changes in Mn
concentration in the brain, kidney, femoral bone, or heart
muscle of P14 Mn-exposed pups [Fig. 3]. In 8-week-old
rats, the concentration of Mn in all examined tissues was
comparable between control and Mn-exposed rats
[Figs. 4, 5].

GPx activity was measured by the kinetic method of Paglia
and Valentine (1967). In this method, GPx catalyzes the
reaction between reduced glutathione (GSH) and t-butyl
hyperoxide. The resulting oxidized glutathione (GSSG) is
then converted back to the reduced form (GSH) by a
NADPH-dependent glutathione reductase (GR). This
reaction results in decreased absorbance at 340 nm which
is directly proportional to the GPx activity. The decrease in
absorbance was measured by an automated analyzer Perkin
Elmer. The activity of GPx was expressed as micromoles
of NADPH oxidized per minute per g protein (U/g Hb).
Determination of Catalase (CAT) Activity
Catalase activity was measured by the method of Johansson and Borg (1988) using an automated Perkin Elmer
analyzer. This method is based on the reaction of the
enzyme with methanol in the presence of optimal concentrations of hydrogen peroxide. Generated formaldehyde
is measured spectrophotometrically at 550 nm as a purple
dye. The activity of CAT was expressed as U/g protein.

Fig. 1 Brain region-specific manganese content in rat dams exposed
to manganese (10,000 ppm) during pregnancy and for the first
21 days after birthing (n = 5–6). Legend: open square control filled
light gray square Mn (10,000 ppm) * p \ 0.05; ** p \ 0.001

Data Analysis
For the Mn assay, Student’s t test was used to estimate the
significance of the differences between groups. For the
remainder of data, two-way analysis of variance (ANOVA)
and the post-ANOVA test of Neuman–Keuls were used to test
the differences between groups for significance. A p value of
0.05 or less was used to indicate a significant difference.
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Fig. 2 Tissue- and organ-specific manganese content in rats dams
exposed to manganese (10,000 ppm) during pregnancy and for the
first 21 days after birthing (n = 5–6). Legend is the same as in Fig. 1
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Fig. 3 Manganese content in the brain and other tissues and organs in
P14 rats pups exposed to this metal (10,000 ppm) during pre- and
perinatal development (n = 5–6). Legend is the same as in Fig. 1. *
p \ 0.05; ** p \ 0.01

Fig. 4 Brain region-specific manganese content in 8-week-old rats
exposed to this metal (10,000 ppm) during pre- and perinatal
development (n = 6). Legend is the same as in Fig. 1

5

60, or 134 lg) at P3 was associated with significantly
elevated 2.3- and 2.5-DHBA levels in the brain in comparison to control. Similar effects were also observed in
P14 Mn-exposed rats injected at P3 with 6-OHDA (Mn vs.
Mn ? 6-OHDA). Mn exposure alone resulted in an
increase in DHBA (p \ 0.05) in comparison to control
animals. Furthermore, in Mn-exposed rats pretreated with
6-OHDA, a significant elevation in DHBA was observed
when compared to the group receiving Mn alone. Salicylic
acid levels did not differ among the groups of 14-day-old
rats [Table 1].
In prefrontal cortex of 8-week-old rats, 2.3-DHBA was
elevated in control rats (i.e., no Mn exposure) treated at P3
with 6-OHDA at doses of 60 and 134 lg, whereas 2.5DHBA levels were elevated in all 6-OHDA groups (30, 60,
and 134 lg). Mn exposure alone resulted in a significant
increase in 2.3- and 2.5-DHBA contents in prefrontal
cortex versus rats without Mn exposure. 6-OHDA treatment did not enhance effects of Mn on 2.3- and 2.5-DHBA
contents [Table 2]. Similar effects relating to 6-OHDA
treatment and Mn exposure were observed in the hippocampus [Table 3] and thalamus [Table 4]. In the brain
stem, 2.3-DHBA contents were unaltered at 8 weeks after
6-OHDA and/or Mn exposure. However, 2.5-DHBA was
elevated in control rats (i.e., no Mn exposure) treated at P3
with 6-OHDA (30 and 60 lg) and in rats exposed perinatally to Mn and not treated at P3 with 6-OHDA [Table 5].
No significant changes in 2.3- and 2.5-DHBA were
observed in the cerebellum [Table 6]. In the neostriatum,
6-OHDA treatment (60 or 134 lg) at P3 significantly elevated 2.3- and 2.5-DHBA levels at 8 weeks. Similar effects
were also observed in rats exposed perinatally to Mn.
Moreover, in Mn-exposed rats that were treated at P3 with
6-OHDA, 2,3- and 2,5-DHBA levels were further elevated.
Salicylic acid levels did not differ among the groups of
8-week-old rats [Table 7].
Assessment of 2.3- and 2.5-dihydroxybenzoic acid
Microdialysate Contents

Fig. 5 Tissue- and organ-specific manganese content in 8-week-old
rats exposed to this metal (10,000 ppm) during pre- and perinatal
development (n = 6). Legend is the same as in Fig. 1

Assessment of 2.3- and 2.5-dihydroxybenzoic Acid
and Salicylic Acid in Tissue Samples
The generation of HO• was estimated from the production
of 2.3- and 2.5-DHBA after systemic (i.p.) salicylic acid
administration. In 14-day-old rats, 6-OHDA treatment (30,

After switching aCSF to aCSF with 5 mM salicylic acid
(point ‘‘0’’ on the graph), 2.3- and 2.5-DHBA appeared in
the microdialysates of the neostriatum. The formation of
2.3-DHBA stabilized at 44 min in control and Mn-exposed
rats and reached a concentration of *100 pg/20 ll in both
groups. In control rats treated at P3 with 6-OHDA (134 lg)
as well as in Mn-exposed rats treated at P3 with 6-OHDA
(134 lg), 2.3-DHBA levels stabilized at 66 min and
attained a concentration of *180 pg/20 ll. Significant
differences between control and control ? 6-OHDA
groups were observed at 88, 110, 132, 154, and 176 min
(p \ 0.05), whereas differences were observed between
Mn and Mn ? 6-OHDA groups at 88, 110, and 132 min of
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6.25 ± 0.73
20.28 ±2.72
22.75 ± 2.50

2.3-DHBA (ng/g)

2.5-DHBA (ng/g)

SAL (lg/g)

9.05* ± 1.13
22.83 ± 2.44

29.13* ± 3.24
25.71 ± 0.75

30.21* ± 2.87

10.52** ± 0.91

8.70# ± 0.69
23.23 ± 1.97

28.39# ± 1.23
24.09 ± 1.50

38.13* ± 4.22

12.17* ± 1.26

6-OHDA
(30 lg)

26.23 ± 1.99

32.93* ± 2.74

10.03 ± 0.91

6-OHDA
(60 lg)

25.70 ± 2.30

41.01* ± 5.23

11.36* ± 1.17

6-OHDA
(134 lg)

3.25 ± 0.45
17.68 ± 0.81
11.05 ± 0.64

2.3-DHBA (ng/g)

2.5-DHBA (ng/g)

SAL (lg/g)

4.40 ± 0.56
12.78 ± 1.73

25.88* ± 2.60

4.66* ± 0.35
11.23 ± 0.40

28.48** ± 2.98

## p \ 0.005 control versus manganese

# p \ 0.05

14.18 ± 1.55

38.15** ± 5.15

4.69* ± 0.49

6-OHDA
(134 lg)

13.44 ± 1.53

26.32## ± 2.57

4.90# ± 0.59

0.9 %NaCl

6-OHDA
(60 lg)

0.9 %NaCl

6-OHDA
(30 lg)

Mn

Control

** p \ 0.005 control versus control ? 6-OHDA or manganese versus manganese ? 6-OHDA

* p \ 0.05

Prefrontal cortex

Part of the brain

10.75 ± 0.88

21.28 ± 2.38

4.58 ± 0.61

6-OHDA
(30 lg)

10.94 ± 1.52

26.42 ± 4.39

4.39 ± 0.63

6-OHDA
(60 lg)

13.81 ± 1.36

24.92 ± 1.19

5.62 ± 0.76

6-OHDA
(134 lg)

Table 2 Concentrations of 2.3- and 2.5-DHBA and salicylic acid in the prefrontal cortex of adult rats exposed to manganese (10,000 ppm) during pre- and perinatal development (n = 5–7)

# p \ 0.05 control versus manganese

23.83 ± 3.63

30.65* ± 2.74

11.25* ± 1.57

6-OHDA
(134 lg)

0.9 %NaCl

6-OHDA
(60 lg)

0.9 %NaCl

6-OHDA
(30 lg)

Mn

Control

* p \ 0.05
* p \ 0.001 control versus control ? 6-OHDA or manganese versus manganese ? 6-OHDA

Right hemisphere

14-days newborn rats

Table 1 Concentrations of 2.3- and 2.5-DHBA and salicylic acid in the brains of newborn rats exposed to manganese (10,000 ppm) during pre- and perinatal development (n = 6)
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3.55 ± 0.47
16.58 ± 1.29
11.70 ± 1.78

2.3-DHBA (ng/g)

2.5-DHBA (ng/g)

SAL (lg/g)

13.16 ± 1.21

21.32 ± 2.48

5.19* ± 0.61
12.29 ± 1.19

21.76* ± 1.59

4.91 ± 0.60
12.31 ± 0.40

21.43# ± 1.58

4.73# ± 0.33

0.9 %NaCl

13.81 ± 0.88

22.95 ± 1.67

4.62 ± 0.45

11.31 ± 1.18

25.23 ± 2.35

3.78 ± 0.33

6-OHDA
(60 lg)

14.13 ± 1.07

25.81 ± 1.90

5.87 ± 0.89

6-OHDA
(134 lg)

317 ± 0.28
15.48 ± 1.24
10.02 ± 0.59

2.3-DHBA(ng/g)

2.5-DHBA (ng/g)

SAL (lg/g)

3.29 ± 1.48
11.01 ± 1.15

19.44 ± 1.97

4.59* ± 0.38
10.18 ± 0.73

23.08* ± 3.15

# p \ 0.05 control versus manganese

11.42 ± 1.52

27.25** ± 2.16

4.18* ± 0.45

6-OHDA
(134 lg)

12.29 ± 0.57

19.95# ± 1.62

4.39 ± 0.37

0.9 %NaCl

6-OHDA
(60 lg)

0.9 %NaCl

6-OHDA
(30 lg)

Mn

Control

** p \ 0.005 control versus control ? 6-OHDA or manganese versus manganese ?6-OHDA

* p \ 0.05

Striatum

Part of the brain

11.80 ± 0.57

24.10* ± 1.76

6.04* ± 0.50

6-OHDA
(30 lg)

10.21 ± 0.58

25.36* ± 2.33

5.97 ± 0.50

6-OHDA
(60 lg)

12.35 ± 1.52

26.52* ± 2.18

6.28* ± 0.81

6-OHDA
(134 lg)

Table 4 Concentrations of 2.3- and 2.5-DHBA and salicylic acid in the thalamus of adult rats exposed to manganese (10,000 ppm) during pre- and perinatal development (n = 5–7)

# p \ 0.05 control versus manganese

13.24 ± 2.68

30.40* ± 6.70

5.84* ± 0.77

6-OHDA
(134 lg)

6-OHDA
(30 lg)

6-OHDA
(60 lg)

0.9 %NaCl

6-OHDA
(30 lg)

Mn

Control

* p \ 0.05 control versus control ? 6-OHDA or manganese versus manganese ?6-OHDA

Hippocampus

Part of the brain

Table 3 Concentrations of 2.3- and 2.5-DHBA and salicylic acid in the hippocampus of adult rats exposed to manganese (10,000 ppm) during pre- and perinatal development (n = 5–7)
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7.60 ± 0.82
37.21 ± 4.01
14.03 ± 1.44

2.3-DHBA (ng/g)

2.5-DHBA (ng/g)

SAL (lg/g)

16.64 ± 1.93

44.81 ± 4.89

15.64** ± 1.67
18.09 ± 2.15

52.24 ± 9.52

12.92* ± 1.56

21.53# ± 5.46
16.14 ± 1.69

63.06# ± 8.32
16.94 ± 1.66

59.33 ± 4.62

19.84 ± 1.63

6-OHDA
(30 lg)

14.40 ± 1.71

54.64 ± 3.15

19.24 ± 1.47

6-OHDA
(60 lg)

15.02 ± 1.56

62.15 ± 15.39

20.76 ± 5.77

6-OHDA
(134 lg)

Cerebellum

Part of the brain

4.86 ± 0.86
40.10 ± 7.15
11.83 ± 1.34

2.3-DHBA(ng/g)
2.5-DHBA (ng/g)

SAL (lg/g)

12.95 ± 1.33

7.99 ± 1.48
52.56 ± 9.32

11.70 ± 1.26

6.91 ± 1.43
53.59 ± 6.95

11.25 ± 0.47

6.94 ± 1.08
54.09 ± 5.34

6-OHDA
(134 lg)

11.68 ± 0.78

6.99 ± 0.71
45.71 ± 3.47

0.9 %NaCl

6-OHDA
(60 lg)

0.9 %NaCl

6-OHDA
(30 fig)

Mn

Control

12.54 ± 1.00

7.13 ± 0.61
52.02 ± 6.65

6-OHDA
(30 lg)

11.60 ± 1.40

8.16 ± 1.02
54.10 ± 11.66

6-OHDA
(60 lg)

14.36 ± 1.67

8.23 ± 1.16
43.27 ± 4.09

6-OHDA
(134 lg)

Table 6 Concentrations of 2.3- and 2.5-DHBA and salicylic acid in the cerebellum of adult rats exposed to manganese (10,000 ppm) during pre- and perinatal development (n = 5–7)

14.24 ± 1.35

58.63** ± 5.16

8.33 ± 1.05

6-OHDA
(134 lg)

0.9 %NaCl

6-OHDA
(60 lg)

0.9 %NaCl

6-OHDA
(30 lg)

Mn

Control

* p \ 0.05 control versus control ? 6-OHDA or manganese versus manganese ?6-OHDA
# p \ 0.05 control versus manganese

Thalamus and
hypothalamus

Part of the brain

Table 5 Concentrations of 2.3- and 2.5-DHBA and salicylic acid in the brain stem of adult rats exposed to manganese (10,000 ppm) during pre- and perinatal development (n = 5–7)
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10.60 ± 0.63

Assessment of Antioxidant Enzyme Activities
In prefrontal cortex at 8 weeks, SOD and Mn-SOD activities were decreased in rats that had been treated at P3 with
6-OHDA (134 lg) as well as in Mn and Mn ? 6-OHDA
groups versus control. Also, concurrently in Mn ? 6OHDA, rats activities of these enzymes were significantly
elevated versus respective controls (Mn alone exposed
rats). GST was decreased in Mn and Mn ? 6-OHDA
groups versus control, while GPx was significantly elevated in Mn ? 6-OHDA rats (versus control and Mn
groups). Activities of CuZn-SOD, GR, and catalase were
unchanged [Fig. 8]. In hippocampus, only GPx activity
was changed (elevated in 6-OHDA and Mn groups);
activity of other enzymes was unchanged [Fig. 9]. In striatum SOD and CuZn-SOD, activities were decreased in
6-OHDA, Mn, and Mn ? 6-OHDA groups. Significant
decreases in Mn-SOD (only in Mn alone exposed rats),
GST (Mn and Mn ? 6-OHDA), and GR (6-OHDA)
activities [Fig. 10]. In thalamus and hypothalamus,
6-OHDA (134 lg) produced significant decreases in the
activities of GST and GR, Mn in GST and catalase, and
Mn ? 6-OHDA in GST activity [Fig. 11]. In cerebellum,
CuZn-SOD activity was decreased in 6-OHDA-lesioned
rats as well as in Mn alone exposed rats and Mn ? 6OHDA rats. Also, GST activity was decreased in the
Mn ? 6-OHDA versus control (Mn alone). Conversely,
GR activity was elevated in Mn-exposed rats as compared
to controls [Fig. 12]. In brain stem, 6-OHDA (134 lg)
produced a decrease in the activities of SOD, Mn-SOD,
CuZn-SOD, and GR; also a reduction in Mn-SOD activity
was found in the Mn ? 6-OHDA group. Furthermore, GST
was decreased in the 6-OHDA group, Mn and Mn ? 6OHDA rats versus controls [Fig. 13].

* p \ 0.05

Discussion
# p \ 0.05 control versus manganese

11.94 ± 1.58
11.31 ± 1.14
SAL (lg/g)

** p \ 0.005 control versus control ? 6-OHDA or manganese versus manganese ?6-OHDA

9.30 ± 0.30

10.23 ± 0.80

10.06 ± 0.95

9.69 ± 0.85

testing [Fig. 6]. With respect to the 2.5-DHBA microdialysate, significant differences between control vs. control ? 6-OHDA and Mn vs. Mn ? 6-OHDA were noted
between 88 and 220 min of the experiment [Fig. 7].

10.12 ± 1.07

4.81 ± 0.75

24.99 ± 2.00
32.50 ± 3.04

4.61 ± 0.61
4.64 ± 0.59

36.46 ± 3.64
37.41# ± 4.61

5.02 ± 0,59
5.60 ± 1.42

31.41 ± 4.13

5.87 ± 0.98

42.43* ± 6.27

4.23 ± 1.19

26.00 ± 2.51

2.3-DHBA (ng/g)
Brain stem

2.5-DHBA (ng/g)

5.55 ± 0.75
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35.41* ± 3.26

6-OHDA (134 lg)
6-OHDA (60 lg)
6-OHDA (30 lg)
0.9 %NaCl
0.9 %NaCl

6-OHDA (30 lg)

6-OHDA (60 lg)

6-OHDA (134 lg)

Mn
Control
Part of the brain

Table 7 Concentrations of 2.3- and 2.5-DHBA and salicylic acid in the neostriatum of adult rats exposed to manganese (10,000 ppm) during pre- and perinatal development (n = 5–7)
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In the present study, we demonstrated that Mn content in
the brain (frontal cortex, hippocampus, and neostriatum),
kidney, liver, and bone was significantly elevated in rat
dams exposed to this metal during pregnancy. Conversely,
in neonates (P14) whose mothers were exposed to Mn
during the prenatal and perinatal periods, Mn primarily
accumulated in the femoral bone and liver. In P14 pups, no
significant differences in Mn content in other tissues (brain,
kidney, femoral muscle, and heart) were noted in comparison to control. Interestingly, Mn accumulation in the
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Fig. 6 Striatal microdialysate
2.3-DHBA concentrations in
control and manganese-exposed
(10,000 ppm) rats lesioned with
6-OHDA (n = 5–7). Legend:
open diamond control open
square manganese filled
diamond control ? 6-OHDA
(134 lg) filled square
manganese ? 6-OHDA
(134 lg) * p \ 0.05 control
versus control ? 6-OHDA
(134 lg) # p \ 0.05 manganese
versus manganese ? 6-OHDA
(134 lg)

Fig. 7 Striatal microdialysate
2.5-DHBA concentrations in
control and manganese-exposed
(10,000 ppm) rats lesioned with
6-OHDA (n = 5–7). Legend is
the same as in Fig. 6

femoral bone and liver was not observed in 8-week-old
Mn-exposed rats. This is in agreement with other reports
indicating that Mn can be transiently deposited in various
rat tissues (mostly in the liver), both after parenteral and
oral administration (Roels et al. 1997). Dorman et al.
(2005) showed that newborn rats exposed to Mn via aerosol
inhalation during lactation had a 2–3-fold increase in Mn
content in brain and in other tissues (stomach, blood, liver,
and skull cap); however, following cessation of Mn
administration, tissue Mn concentrations returned to control values by P45 in all offspring tissues. Others have
demonstrated that the level of Mn in perinatally exposed
pups was 6–8 times higher than in controls. When Mn
intoxication was discontinued, the Mn contents decreased
nearly to control levels (Kostial et al. 2005). The data cited
above largely corroborate the present findings. It is notable
that Siddappa et al. (2002) and Garcia et al. (2006)
observed that the expressions of proteins involved in Mn
transport, i.e., divalent metal transporter-1 (DMT-1) or
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transferrin receptors in the central nervous system (cerebral
cortex, hippocampus, and neostriatum), appear in rats at
P5. This may, at least in part, explain the results of our
study concerning the lack of accumulation of this metal in
the brains of neonates (14-day-old rats). These studies, as
well as our own observations, indicate that Mn crosses the
placenta. Although, in contrast to the other heavy metals
(cadmium, lead) (Brus et al. 1995; Nowak et al. 2006;
Szczerbak et al. 2007), Mn is not deposited in the tissue for
long periods of time. Following cessation of Mn exposure,
Mn is very quickly and efficiently eliminated by the body.
To determine the possible role of HO• generation in Mninduced neurotoxicity, we estimated the content of 2.3- and
2.5-DHBA (spin trap products of salicylate; HO• provides
an index of in vivo reactive oxygen species generation).
We demonstrated that DA denervation resulted in
enhancement of HO• formation in the brains of newborn
rats. Similar data were obtained from adult animals (8week-old rats lesioned with 6-OHDA at a dose of 30, 60, or
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Fig. 8 Antioxidant enzymes activity in prefrontal cortex of adult
control and manganese-exposed (10,000 ppm) rats lesioned with
6-OHDA (n = 8). Legend: open square control filled light gray bar
control ? 6-OHDA (134 lg) filled dark gray bar manganese filled
black square manganese ? 6-OHDA (134 lg) * p \ 0.05; **
p \ 0.01 control versus 6-OHDA; control versus manganese; control
versus manganese ? 6-OHDA # p \ 0.05 manganese versus manganese ? 6-OHDA

Fig. 9 Antioxidant enzymes activity in hippocampus of adult control
and manganese-exposed (10,000 ppm) rats lesioned with 6-OHDA
(n = 8). Legend is the same as in Fig. 8. * p \ 0.05; ** p \ 0.01
Control versus 6-OHDA and control versus manganese

Fig. 10 Antioxidant enzymes activity in striatum of adult control and
manganese-exposed (10,000 ppm) rats lesioned with 6-OHDA
(n = 8). Legend is the same as in Fig. 8. * p \ 0.05; ** p \ 0.01
control versus 6-OHDA; control versus manganese; control versus
manganese ? 6-OHDA
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Fig. 11 Antioxidant enzymes activity in thalamus and hypothalamus
of adult control and manganese-exposed (10,000 ppm) rats lesioned
with 6-OHDA (n = 8). Legend is the same as in Fig. 8. * p \ 0.05;
** p \ 0.01 control versus 6-OHDA; control versus manganese;
control versus manganese ? 6-OHDA

Fig. 12 Antioxidant enzymes activity in cerebellum of adult control
and manganese-exposed (10,000 ppm) rats lesioned with 6-OHDA
(n = 8). Legend is the same as in Fig. 8. * p \ 0.05; ** p \ 0.01
control versus 6-OHDA; control versus manganese; control versus
manganese ? 6-OHDA #p \ 0.05 manganese versus manganese ? 6-OHDA

Fig. 13 Antioxidant enzymes activity in brain stem of adult control
and manganese-exposed (10,000 ppm) rats lesioned with 6-OHDA
(n = 8). Legend is the same as in Fig. 8. * p \ 0.05; ** p \ 0.01
control versus 6-OHDA; control versus manganese; control versus
manganese ? 6-OHDA
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134 lg at P3). In the current study, 2.3-DHBA and 2.5DHBA contents were significantly increased in the frontal
cortex, hippocampus, neostriatum, thalamus with hypothalamus, and pons of 6-OHDA-lesioned rats. Additionally,
there was no association between the extent of DA
denervation and increased HO• formation. These data are
in agreement with the results published by Kostrzewa et al.
(2000) who found that in the DA-denervated neostriatum
(6-OHDA, 134 lg), 2.3-DHBA was increased more than
4-fold, and 2.5-DHBA was increased 2.5-fold in comparison to fully DA-innervated rats.
An important novelty of our work is the demonstration
that HO• overproduction was observed not only in rats with
profound dopaminergic system damage (6-OHDA,
134 lg), but also in animals with intermediate (6-OHDA,
60 lg) and minor (6-OHDA, 30 lg) DA depletion. This
indicates that even modest injury to the dopaminergic
system acts as a ‘‘trigger mechanism,’’ initiating a cascade
of adverse signaling events that lead to a protracted
increase in HO• generation. Concurrently, we showed that
if this process is launched in early postnatal life (14-dayold rats), then it persists throughout adult life. One
hypothesis that could explain this phenomenon is that
6-OHDA administered to laboratory animals induces upregulation of DMT-1 localized on DA neurons, with subsequent increases in iron overload—a possible substrate for
HO• production (Fenton reaction) (Song et al. 2007; Jiang
et al. 2010). Furthermore, others found reduced expression
of ferroportin 1 and hephaestin in the substantia nigra of
6-OHDA-lesioned rats. These two iron export proteins are
involved in removal of this metal from neurons in the
substantia nigra (Wang et al. 2007). This hypothesis could
also serve as an explanation for the absence of changes in
DHBA in the cerebellum, since the cerebellum has sparse
dopaminergic innervation, and abnormal iron homeostasis
seems to be of marginal relevance to this part of the brain.
In the present work, we also showed that perinatal Mn
exposure increases the generation of HO• in the brains of
newborn rats; in the frontal cortex, hippocampus, thalamus
with hypothalamus, and partly in the pons at 8-weeks.
Moreover, 6-OHDA-induced DA denervation enhanced
this effect in the neostriatum at P14 and through 8 weeks.
Because of the latter effect, it was of interest to assess
neostriatal extraneuronal HO• levels. We found that microdialysate levels of both 2.3- and 2.5-DHBA were significantly elevated in DA-denervated neostriatum. These
results were counter to our expectation because the extraneuronal compartment is effectively protected by various
antioxidants (e.g., ascorbic acid, uric acid, etc.) prior to
HO• formation. Additionally, endogenous melatonin may
play an active role in maintaining oxidative homeostasis in
the extracellular compartment of the neostriatum (Rocchitta et al. 2005). Extracellular ascorbic acid
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concentrations in the neostriatum range between 350 and
500 lM, similarly to uric acid; and increases by *50 %
following an increase in evoked DA release (e.g., after
systemic amphetamine injection) (Miele and Fillenz 1996).
Interestingly, no differences were found in microdialysate contents of 2.3- and 2.5-DHBA in the neostriatum
between Mn-exposed and control rats. These results are
counter to findings on isolated neostriatal tissues. However,
in isolated neostriatal tissues, the measurement of the
intensity in HO• generation reflects an intracellular compartment, which represents more than 90 % of its weight,
as well as the extraneuronal compartment. Furthermore,
extracellular HO• is dwarfed by the intraneuronal environment wherein the majority of metabolic processes occur
(mitochondria, lysosomes, etc.). These considerations find
confirmation in the work by Milatovic et al. (2007, 2009)
who showed that Mn induces neuronal damage through
oxidative injury and mitochondrial dysfunction (intracellular compartment). Conversely, it is known that DA is a
source of free radicals, which are formed during its enzymatic metabolism (monoamine oxidase), or by non-enzymatic autoxidation that leads to production of highly
reactive DA quinones and DA semiquinones (Halliwell
2006). Under conditions of a marked DA deficit, glutamate
could initiate free radicals formation through stimulation of
intracellular signaling, in the process termed excitotoxicity.
This hypothesis is supported by the study of Golembiowska
and Dziubina (2012) who showed that a marked increase in
striatal extracellular glutamate level in rats with 6-OHDAinduced DA depletion could account for enhanced extraneuronal formation of hydroxyl radicals. Conversely, restoration of the striatal DA-glutamate balance suppressed
6-OHDA-induced overproduction of hydroxyl radical. In
our recently published study in which the same experimental model was engaged (as in the present work), we
found no difference in extraneuronal DA in control versus
Mn-exposed rats (Szkilnik et al. 2014). Under the
assumption that Mn exposure minimally affected the extraneuronal milieu (i.e., DA release), we cannot expect
overt changes in extraneuronal hydroxyl radical formation.
DHBA studies coincide with antioxidant enzyme
activity deterioration that we found in the brains of rats
lesioned with 6-OHDA and/or intoxicated with Mn. The
most prominent impairments were observed in the prefrontal cortex, striatum, and brain stem i.e., significant
decrease in activity of SOD isoenzymes and GST was
noted in 6-OHDA-, Mn-, and Mn ? 6-OHDA groups in
comparison to control. In mammals, SODs represent the
major antioxidant defense system against superoxide anion
(O•2 ). We hypothesize that ineffectiveness of SOD activity
may result in accumulation of O•2 which, in turn, in the
presence of hydrogen peroxide (H2O2) (Haber–Weiss
reaction) brings about enhancement of HO• generation, the
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effect demonstrated in the current study. Furthermore, from
our work, we have also learned that H2O2 cleavage
mechanisms are nearly unaffected (in exception with prefrontal cortex and hippocampus) because negligible changes in catalase and glutathione-associated enzymes activity
were found. Our data are in agreement with others who also
demonstrated that 6-OHDA treatment resulted in impairment (decrease) in antioxidant enzymes activity in rats and
mice (Ahmad et al. 2012; Haleagrahara et al. 2013). Also,
Santos et al. (2012) found that in rats injected ip for 4 or
8 days with 25 mg MnCl2/kg/day, a significant increase in
Mn-SOD protein expression was noted in brains after 4 Mn
doses, but the expressions of these proteins were decreased
after 8 Mn doses. Chtourou et al. (2010) demonstrated that
Mn intoxication (20 mg/ml manganese chloride in drinking
water for 30 days) was accompanied by a decrease of
enzymatic (SOD, CAT, and GPx) and non-enzymatic
(glutathione and ascorbic acid) antioxidants in the rat’s
cerebral cortex.
In summary, the current study demonstrates HO• overproduction in brain tissue (prefrontal cortex, hippocampus,
thalamus/hypothalamus, striatum) and in striatal in vivo
(extraneuronal) microdialysates of adulthood rats, despite
lack of a measurable residual of Mn consequent to perinatal
Mn exposure (i.e., Mn addition to the drinking water of
mother rats during gestation and through the 21 day
suckling period). Moreover, HO• elevation was enhanced
in perinatal Mn-exposed rats by mild-, moderate-, or
extensive-postnatal 6-OHDA lesioning of dopaminergic
neurons, which alone resulted in increased tissue- and
microdialysate levels of HO•. On the basis of this study, it
appears that perinatal Mn exposure may represent a lifelong risk toward the incidence or severity of neurodegenerative disorders, such as Parkinson’s disease, in humans.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
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Parkinsonian syndrome In methcathinone users and the role of
manganese. N Engl J Med 358:1009–1017
Szczerbak G, Nowak P, Kostrzewa RM, Brus R (2007) Maternal lead
exposure produces long-term enhancement of dopaminergic
reactivity in rat offspring. Neurochem Res 32:1791–1798
Szkilnik R, Brus R, Malinowska-Borowska J, Nowak D, Waliczek M,
Kostrzewa RM, Nowak P (2014) Ontogenetic manganese
exposure with perinatal 6-OHDA lesioning alters behavioral
responses of rats to dopamine D1 and D2 agonist treatments.
Environ Toxicol Pharmacol 37:28–36
Takeda H, Matsumiya T, Shibuya T (1990) Detection and identification modes for the highly sensitive and simultaneous determination of various biogenic amines by coulometric highperformance liquid chromatography. J Chromatogr 515:265–278
Wang J, Jiang H, Xie JX (2007) Ferroportin1 and hephaestin are
involved in the nigral iron accumulation of 6-OHDA-lesioned
rats. Eur J Neurosci 25:2766–2772
Wasserman GA, Liu X, Parvez F, Ahsan H, Levy D, Factor-Litvak P,
Kline J, van Geen A, Slavkovich V, Loiacono NJ, Levy D,
Cheng Z, Graziano JH (2006) Water manganese exposure and
children’s intellectual function in Araihazar, Bangladesh. Environ Health Perspect 114:124–129
Whiteside P (1976) Atomic absorption. Pye Unicam Ltd., Cambridge,
England
Woolf A, Wright R, Amarasiriwardena C, Bellinger D (2002) A child
with chronic manganese exposure from drinking water. Environ
Health Perspect 110:613–616
Zhang J, Cao R, Cai T, Aschner M, Zhao F, Yao T, Chen Y, Cao Z,
Luo W, Chen J (2013) The role of autophagy dysregulation in
manganese-induced dopaminergic neurodegeneration. Neurotox
Res 24:478–490

